Lipitor

Lipitor is a member of the drug class known as statins. It is prescribed to reduce the amount of cholesterol and other fatty substances in the blood. While some level of cholesterol is necessary to maintain good health, high and low levels of different types of cholesterol are associated with increased risk of arterial blockage, with can lead to heart attacks and strokes. Lipitor was designed to block an enzyme and prevent cholesterol synthesis in the liver, thereby lowering cholesterol. However, the use of Lipitor has been associated with an increased risk of developing diabetes in women. If you or a loved one has used or is using Lipitor, read on for facts about this drug and the litigation surrounding it.

Facts about Lipitor:

  • Lipitor, originally manufactured by Warner-Lambert and now manufactured by Pfizer, was first approved by the FDA and hit the U.S. market in 1997. Lipitor was marketed to significantly help reduce cholesterol more than its competitors. After only 10 months on the market, Lipitor became the most prescribed statin in the U.S. Lifetime sales for Lipitor exceed $130 billion. In the United States alone, more than 17 million people have been prescribed Lipitor.
  • As early as 2004, studies showed an increased risk of developing diabetes from using diabetes. Unfortunately, a lack of data for woman in studies made the true risk to women undetectable for years. Studies and data available that allows for evaluation based on gender shows an increased risk of diabetes in women compared to men.
  • In 2012, the FDA required label changes for the entire statin drug class. However, this label change did not reference diabetes.
  • A 2013 study found a significant relationship between the percent of women in statin trials and the risk of developing diabetes.

Litigation News:

  • Numerous lawsuits have been filed across the country by women alleging injuries as a result of Lipitor ingestion, including a number of cases filed in the District of South Carolina that have been consolidated before Judge Richard Gergel.
  • On August 8, 2013, the Judicial Panel on Multidistrict Litigation (JPMDL) denied a petition filed by plaintiffs to centralize all Lipitor cases into a Multidistrict Litigation (MDL). The Court cited the South Carolina consolidation, as well as the limited number of cases filed by that time, as reason for denying the MDL.
  • Since that time, dozens of Lipitor cases have been filed across the country, including lawsuits filed by Johnson Becker Partner Timothy Becker and will continue to be so. Plaintiffs continue consolidated efforts to move the litigation forward.

If you or a loved one has used or is using Lipitor and has suffered from diabetes, or you have lost a loved one for one of these reasons, find out how Johnson Becker, PLLC can help you. Please either call us at our toll free number (800) 279-6386 or fill out our case review form here on our website and submit it for a free consultation.

FREE CONSULTATION: